i agree with the drisa side but not the aa. if it gets the aa then that signals approval and an aa indicates end of december approval without the adcom. since the adcom is not scheduled i think it will not be done. if the aa comes out srpt is 60 and 100 on approval. i am betting on 100.
why don't you take all of your money - what's left of it - and short the hell out of srpt. i encourage all of you nedgative nellies to short. we need the rocket full for the 15-0 adcom in january or the out of the blue end of december fda approval. -- yeah short the h_ll out of it. i dare you.
and i hope the skip the adcom and go right to the accelearted approval and approval at the end of december. they know what etep is and the kids deserve something now.
after th bmrn adcom bmrn will get rejected or at best a crl. that means there is only one treatement left. there is no way the fda will not give those kids a treatment or delay it 1 to 2 years. that means etep will ultimately be approved.
the next 3 months.
since the fda will approve etep it will cancel the adcom -- no sense putting any doubt on etep. the only issue is whether it will geve the accelerated approval which i have said before - the will. worse case they go out into february. now when the cancel the adcom the shorts will spin it negatively and take the price down, but they will have to close by the third week december or risk waking up with an early approval.
this will be aproved and will be 100 after the approval. i hope they keep shorting and get waffled on the approval
why at this stage of the game do you bother to respond to the anti srpt or the back had slap. everyone's response should be the same --- if you are negative on srpt and you are long then why don't you sell your position. if you are negative and not long then if you have conviction then short or short some more if you are short . i don't understand the constant replies to the same garbage after all these years.
then post again with the negativity --once again here is the difference -- srpt shows efficacy ( for the stupid it means it works) and there is no safety issues finally srpt followed all of the protocols required by the fda unlike bmrn. stop with the nonsense. srpt is the closest to a slam dunk that you can get in the development stage bio techs.
i always like the subjective assessments like this. you say dumped soneone else says buy. there are two involed a buyer and a seller. i believe that with bmrn halted i think the shorts are playing today and they can since there will be no srpt news for awhile.
i don't believe that srpt trading today is too correlated to the bmrn adcom. ibb is down and so are all the other bio's about the same percentage as srpt. the bio etf's have a big impact on short term trading.
you short srpt liked you threatened to yesterday. tell us now johnnyzzzz - did you short. remember the yahoo mb rule -- you have to own up to shorting buying and selling when you do it not after a major uptick or downturn --- what is your current position. to reiterate -- i encourage you to short short and short some more.
johnny boy when did you close your short -- i bet it was at the 52 week lright? you are the gigeest bs-tter that i have seen on any board. lol
is still posted. simply stated -- srpt has efficacy and safety neither of which bmrn can claim. furthermore, srpt has complied with all of the directives from the fda -- bmrn has not. bmrn will get a crl at best at the end of december or an outright rejections. as i have said in another post i beleive that in several weeks the srpt adcom will be canceled and shortly after an accelerated approval granted with approval arriving in late december. the pear guy, new, simp and all other negative nellies need to ignored. the brmm srpt debate is over.
blah blah blah -- negative nellie -- do you have anything else to do than follow me around on the srpt board and post negative bs. i encourage you and all the rest of the shorts and others to close your shorts and if you and the others like the pear guy -- if you are long i don't know how you would keep you position given all of your doubts
but he said he wasn't bashing. he should sell if he doesn't understand that srpt has efficacy safety and conformed with all of the fda requested processes and steps. i expect the srpt adcom to be cancelled in about 2 weeks followed shortly after with an accelerated approval doc and approval at the end of december.
as confident and #$%$ off as you are i think you should go over ans short srpt. that would serve em right hahahahahahahaah
Simple, bmrn is a big bio with 750 million in revenue. It is not like a developmental stage bio with all their irons in the fire. They have a decent bottom line. Even without dris the analyst think it will double.